Mojtabaee M, Sadegh Beigee F, Ghorbani F
Lung Transplantation Research Center (LTRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Lung Transplantation Research Center (LTRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Transplant Proc. 2017 Oct;49(8):1708-1711. doi: 10.1016/j.transproceed.2017.06.039.
Brain-dead pediatric donors have always been the focus of attention because of the higher quality, utility, and possibility of their organ donation. However, donors under the age of 5 years always necessitate making more challenging management efforts, which are not clearly implied in most parts of the guidelines.
The data obtained from 79 brain-dead pediatric donors of the Organ Procurement Unit of Masih Daneshvari Hospital, Tehran, Iran, were assessed. The donors were divided into 2 groups, including donors under 5 years of age (group A) and those between 5 and 12 years of age (group B). Metabolic, hemodynamic, hematologic, and electrolyte status as well as the suitability for donation were compared in the study groups.
Of 1252 donors, 6.3% were under 12 years of age. Trauma and drug toxicity were the two primary causes of brain death in group A. In comparison, trauma and brain tumor were the leading causes of brain death in group B. The prevalence of both hyperglycemia and respiratory acidosis was significantly higher in group A (P < .05). However, severe anemia and coagulopathy were more prevalent in group B (P < .05). The high-dose inotropic administration was used for 42.4% of the donors in group A, whereas only 26% of the donors in group B needed a high dose of inotropes (P < .05). The mean quantity of organ harvested per donor was 2.1 and 2.25 in groups A and B, respectively. Furthermore, donor loss was not significantly different in both groups.
The occurrence of different complications in donors under the age of 5 years requires special treatment considerations that should be the center of attention in the related guidelines. Organ donation per donor indicates that donors under the age of 5 years are a valuable resource for organ procurement.
脑死亡的儿科供体因其器官捐献质量更高、效用更大且可能性更高,一直是关注焦点。然而,5岁以下的供体总是需要更具挑战性的管理工作,而这在大多数指南中并未明确提及。
对从伊朗德黑兰马西赫·达内什瓦里医院器官获取单位的79名脑死亡儿科供体获得的数据进行评估。将供体分为2组,包括5岁以下的供体(A组)和5至12岁的供体(B组)。比较研究组的代谢、血流动力学、血液学和电解质状况以及捐献适宜性。
在1252名供体中,6.3%年龄在12岁以下。创伤和药物毒性是A组脑死亡的两个主要原因。相比之下,创伤和脑肿瘤是B组脑死亡的主要原因。A组高血糖和呼吸性酸中毒的发生率均显著更高(P < 0.05)。然而,严重贫血和凝血病在B组更普遍(P < 0.05)。A组42.4%的供体使用了高剂量的血管活性药物,而B组只有26%的供体需要高剂量的血管活性药物(P < 0.05)。A组和B组每个供体收获的器官平均数量分别为2.1个和2.25个。此外,两组的供体损失无显著差异。
5岁以下供体出现的不同并发症需要特殊的治疗考虑,这应成为相关指南关注的核心。每个供体的器官捐献表明5岁以下的供体是器官获取的宝贵资源。